September 26, 2016 3:03 AM ET

Healthcare Equipment and Supplies

Company Overview of Innocoll Holdings plc

Executive Profile

A. James Culverwell BSc.

Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee, Innocoll Holdings plc
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships
60$186,530

Background

Mr. A. James Culverwell, BSc. serves as a Principal of Sudbrook Associates LLP, an FSA regulated healthcare corporate finance firm part owned by New Smith Capital Partners in the City of London. Mr. Culverwell has over 30 years experience in the pharmaceutical industry through a successful career in pharmaceutical company analysis, investment banking and latterly in healthcare private equity. He joined Hoare Govett in 1982. Mr. Culverwell served as Director of European ...

Corporate Headquarters

Monksland Business Park
Athlone, Co. Westmeath --

Ireland

Phone: 353 9 0648 6834
Fax: --

Board Members Memberships

2016-Present
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

MS
University Of Aberdeen

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Total Number of Options$4,320

Total Compensation

Total Annual Cash Compensation$48,992
Total Calculated Compensation$186,530
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$477.4K
José E. Almeida Chairman and Chief Executive Officer
Baxter International Inc.
$231.5K
Olivier Brandicourt M.D.Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
$2.4M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Innocoll Holdings plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.